Martin Dreyling, MD of University of Munich Hospital in Grosshadern gives an overview of his presentation, CHRONOS-1, which shows the use of copanlisib in B-Cell Lymphoma patients. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
CORRECTION: Follicular Lymphoma subset ORR was 59.7%
MZL group was 69.6%